Developmental administration of valproic acid alters DNA methylation and maternal behavior

Author(s)Collins, Nicholas J.
Author(s)Zimmerman, Catherine W.
Author(s)Phillips, Natalia L. H.
Author(s)Fern, Samantha
Author(s)Doherty, Tiffany S.
Author(s)Roth, Tania L.
Date Accessioned2022-04-13T15:39:06Z
Date Available2022-04-13T15:39:06Z
Publication Date2022-03-14
DescriptionThis is the peer reviewed version of the following article: Collins, N. J., Zimmerman, C. W., Phillips, N. L. H., Fern, S., Doherty, T. S., & Roth, T. L. (2022). Developmental administration of valproic acid alters DNA methylation and maternal behavior. Developmental Psychobiology, 64, 1– 14. https://doi.org/10.1002/dev.22231, which has been published in final form at https://doi.org/10.1002/dev.22231. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited. This article will be embargoed until 03/14/2023.en_US
AbstractExposure to adversity in early development has powerful and potentially lasting consequences on behavior. Previous work in our laboratory using female Long-Evans rats has demonstrated that exposure to early-life maltreatment manifests into alterations in dam behavior, including a perpetuation of the maltreatment phenotype. These observed behavioral changes coincide with changes in epigenetic activity in the prefrontal cortex (PFC). Further, treating dams with a chromatin modifying agent (Zebularine) normalizes methylation and maltreatment phenotypes, suggesting a link between epigenetic programming and phenotypic outcomes. Here, we sought to investigate if administration of a chromatin modifying agent concurrent with the experience of maltreatment normalizes epigenetic activity associated with maltreatment and alters behavioral trajectories. Administration of valproic acid (VPA) transiently lowered levels of global DNA methylation in the PFC, regardless of exposure to nurturing care or maltreatment. When VPA-exposed animals reached adulthood, they engaged in more adverse behaviors toward their offspring. These data provide further evidence linking epigenetic changes in the developing brain with effects on behavior.en_US
SponsorFunding for this work was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD087509) awarded to Tania L. Roth.en_US
CitationCollins, N. J., Zimmerman, C. W., Phillips, N. L. H., Fern, S., Doherty, T. S., & Roth, T. L. (2022). Developmental administration of valproic acid alters DNA methylation and maternal behavior. Developmental Psychobiology, 64, 1– 14. https://doi.org/10.1002/dev.22231en_US
ISSN1098-2302
URLhttps://udspace.udel.edu/handle/19716/30777
Languageen_USen_US
PublisherDevelopmental Psychobiologyen_US
Keywordsearly-life adversityen_US
Keywordsmaltreatmenten_US
Keywordsprefrontal cortexen_US
Keywordsvalproic aciden_US
TitleDevelopmental administration of valproic acid alters DNA methylation and maternal behavioren_US
TypeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Developmental administration of valproic acid alters DNA methylation and.pdf
Size:
2.73 MB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.22 KB
Format:
Item-specific license agreed upon to submission
Description: